Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experienceDaniele Vallisa, Patrizia Bernuzzi, Luca Arcaini, et al.
European Journal of Haematology|April 7, 2022
Mixed T cell CHIMERISM in bone marrow at day+30 after allogeneic stem cell transplantation: Correlation with acute GVHD grades III-IV and no impact on relapse and overall survivalSamantha Guidotti, Simona Bassi, Angela Rossi, et al.
Cancer|December 24, 2003
Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profilesLuca Arcaini, Marco Paulli, Emanuela Boveri, et al.
Blood Transfusion = Trasfusione Del Sangue|March 12, 2015
Safety and efficacy of granulocyte colony-stimulating factor biosimilars in engraftment after autologous stem cell transplantation for haematological malignancies: a 4-year, single institute experience with different conditioning regimensSimona Bassi, Elisa M Stroppa, Carlo F Moroni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2022
Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration CohortsPaul M Barr, Alessandra Tedeschi, William G Wierda, et al.
British Journal of Haematology|January 15, 2016
Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL)Francesco Zallio, Stefania Tamiazzo, Chiara Monagheddu, et al.
Plos One|June 6, 2014
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptorRossana Maffei, Jenny Bulgarelli, Stefania Fiorcari, et al.
Leukemia & Lymphoma|June 23, 2017
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomideRossana Maffei, Stefania Fiorcari, Silvia Martinelli, et al.
Frontiers in Pharmacology|July 15, 2017
The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective StudySara Galimberti, Elena Ciabatti, Giacomo Ercolano, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2021
COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in ItalyLuigi Cavanna, Chiara Citterio, Claudia Biasini, et al.
Pageof 8